by Frank Ellis MD (Oxford) In 1956 a paper was published by Puck & Marcus which heralded a new phase in cellular radiobiology, both experimentally and theoretically. This new knowledge should be incorporated into our thinking about radiotherapy to improve our insight and to improve the lot of our patients. There has been a great increase in our radiobiological knowledge since radiation became of such importance in connexion with warfare and it seems, now, as if the early efforts of radiologists to make radiobiological bricks without factual straw may be improved upon in relationship to the use of radiation for treating cancer.
The Control of Cancer The predilection of metastases for one organ or another implies a soil-seed type of relationship dependent on biochemical or immunity factors which might well prove eventually to be the basis for controlling cancer. Indeed, some control, but not cure, has been imposed by some hormones and chemical substances on some cancers.
As radiotherapists we are conscious of the fact that surgery and radiation are so far the only means by which cancer has been cured. When we consider the ease with which cells from a cancer are known to pass into the blood stream and the tissue spaces the surprising fact is that cancer is ever cured. In using radiotherapy for treating cancer, if we aim to cure it is by eradicating all the malignant cells. We hope they are all within the volume we are treating and that we shall give a sufficient dose to all parts of that volume to destroy all the malignant cells without so damaging the normal tissue as to cause symptoms.
Cure of cancer implies the inability of all the cancer cells in the body to reproduce. It is accepted that, except in rare instances, the possibility of cure, when distant metastases have occurred, does not exist, but if the cancer does not cause death or cause symptoms during life the patient 71 may be said to have undergone a functional cure. Unfortunately, in most instances, the rate of growth of cancer after its clinical diagnosis is such that it begins to dominate the clinical picture in a relatively short time. It follows that we must consider the question of whether a cancer is curable since the philosophy of treatment of a patient must depend on the answer to this question. From this point of view we must consider first of all if it is curable locally. Cancer spreads from the site of origin by the escape of cells which pass into tissue spaces or into capillary or other blood vessels, the number of which, other things being equal, must be related to the volume of the cancer. It follows that growth, whether locally or in metastases, increases the probability of further metastases.
Survival Curves
For any damaging agents, including radiation, a curve relating cell survival to dose can be drawn, the exact shape of which is very important. A curve of the general shape shown in Fig 1 is often referred to as sigmoid and the curve relating dose to damage is the reciprocal of that relating dose to survival. The true sigmoid curve, as referred to in quantitative work, represents a relationship which becomes a straight line on a probit scale as in the case of pharmacological data. It represents a Gaussian distribution. In the case of radiation the relationship of dose to damage is dependent on the mechanism of the action of radiation and the shape of the curve is not a true sigmoid in the above-mentioned sense. It must be noted that a 1 134 Proceedings ofthe Royal Society ofMedicine different curve applies to each set of con-2 ditions of dose and that such a curve 0 drawn for single doses may not be the same as that for fractionated doses. Also the curve in the case of fractionated treatment for one overall time may be different from that for another. to If the scale for the survival is made logarithmic, the curve relating dose to survival takes on a different shape ( Fig  2) . The first part of this graph is curved and the second part is straight. The curved part represents an apparent threshold factor mixed with the lethal effect of the radiation while the straight part is exponential because the proportion of cells damaged by a given dose is constant so that the number of cells damaged by a given dose is proportional z at any time to the number present. 06 F Relationship of Reproductive Integrity to 0.4
Single Dose ofRadiation
Much work has been done recently on w the relationship of dose to the repro-0 ductive integrity of cells (Puck & z Marcus 1956 , Elkind & Sutton 1959 . o.x-The cells are cultured in a similar way to that with which we are familiar in connexion with bacteria. A number of cells estimated with known accuracy is plated out on a suitable culture medium using a technique which allows them to be spread evenly and thinly. The number of colonies which grow under suitable conditions of incubation indicates the number of cells capable of reproducing themselves and thus the proportion of the original cell populationwith'reproductive integrity' can be estimated. If in a sufficient number of experiments the cells cultured are irradiated a graph can be drawn which relates the dose absorbed to the 'integer fraction' of cells retaining the power of reproduction (Fig 2) . This curve has been given relatively precise parameters as a result of a great deal of radiobiological research mainly by Puck and, in this country, by Hewitt & Wilson (1959) of the Westminster Hospital Medical School. The graphs shown here relate the 'integer proportion' to the dose in rads. The 'integer proportion' is the proportion of cells remaining which are capable of reproducing themselves indefinitely and giving rise therefore to colonies of growing cells. The interval between 10-1 and 10-2 represents a reduction of 90% in the cell population and it is seen from curve C that the dose increase to do this is 375 rads and that it applies at all parts of the curve except the first part where an apparent threshold effect enters in. To produce the first reduction to 10% the dose required is 500 rads. The accepted implication of this higher dose for the initial part of the curve is DOSE -RADS Fig 2 Typical X-ray dose response curvesfor cells grown in oxygenated and anoxic conditions. The figure in brackets is the dose increment which on the straight part ofthe curve reduces the survivingfraction to 0 37 of that obtaining before this exposure (referred to byLajtha & Oliver as the 37% dose slope). C and D are the doseresponse curves for mammalian cells exposed to X-rays under oxygenated and anoxic conditions. A and B are enlargements of the initial shoulders ofcurves C and D. E is the dose-response curvefor cells exposed to a-rays that the injury to a cell caused by the radiation is not such as to impair reproductive integrity unless it is added to within a certain time. It is considered that this injury has a 'fading' time of the order of one to three hours and possibly one and a half hours is a reasonable time during which a further injury adds to its effects rather than having to start the process again. It follows also that the lower the dose given the less the efficiency of that dose because the greater is the proportion in it of the threshold part of the dose.
Curve E indicates the state of affairs if one hit or injury to a cell is sufficient as in the case of an injury by a proton, alpha particle or neutron in a chromosome. Under these circumstances there is no apparent threshold and provided a cell is irradiated in the same cell cycle doses are additive, the effect of two or more fractions being the same as that of a single dose of radiation of the same numerical value. Curve D shows that the graph representing doses necessary to produce the same effects under anoxic conditions follows the same 22 23Section ofRadiology Table 1 Number of cells surviving a single dose (840 rads) which gives 99% killing of oxygenated ceUs and 77 % killing of anoxic cells Percentage of tumour mass Tumour dIameter (cm) viable cells 0.1 1.0 2-0 (10' ceUs-1 g) No. ofcells surviving 840 rads 100% Oxygenated 52 x 103 5-2 x 10' 4-2 x 10' 100% Anoxic 1-2 x 10' 1-2 x 10' 9-7 x 108 50%Oxygenated 2 6x 10' 2-6x 10' 2-1 x 107 50% Anoxic 6 x 10' 6 x 107 4-8 x 108 10% Oxygenated 5-2 x 10' 5 2 x 10' 4-2 x 10' 10 % Anoxic 1-2 x 104 1*2 x 107 9*7 x 107 D Oxygenated 2,600 3,350 4,020 *D Anoxic 6,460 8,500 10,250 5'0 6-6 x 101' 3-3 x 1011 7-5 x 10'" 6-6 x 10' 1-5 x 10" 4,460 11,400 *D=Curative dose, i.e. total dose required to sterilize 9/10 tumours (50% viable cells) general form but that the doses required are about 2-5 times as great as under oxygenated conditions. Table 1 gives quantities taken from the graph of cells killed by various doses. 99 % seems a high proportion but it is easy to realize that there may none the less be a very large number of cells remaining.
Summarized Facts Regarding Survival of Reproductive Integrity Certain facts known in connexion with the work on survival of reproductive integrity of cells are listed below:
(1) The principles implied in the survival curves apply to all the types of cells tested so far.
(2) The dose relationship (i.e. slope of the graph) is said to apply to all types of mammalian cells so far tested both in vitro and, for mouse leukeemia, in vivo.
(3) As shown by Hewitt & Wilson (1959) an average of 2 cells was required to transplant leukwmia in a certain strain of mice. Using this method as a test of survival of cells they were able to draw a survival curve with a 37 % dose-slope value of 160 rads for 60Co gamma radiation as shown by the slope of the graph relating log survival to dose. This figure is virtually true for the slope of the survival curve obtained by Puck and his colleagues plating out irradiated cell suspensions on culture medium. Hence this survival curve is frequently called a Puck-Hewitt curve.
(4) Because of the threshold effect the cells being irradiated appear less sensitive as estimated by the effect/dose ratio with small fractions than with large fractions. For instance, with 100 r -10% killed Sensitivity=0 1 I%Y/rad 500 r -90% killed Sensitivity=0-18 %/rad (5) The extrapolation number varies but is considered, in general, to be proportional to the number of sensitive targets which must be injured in each cell to make it unable to reproduce. Thus, if the straight line portion of the survival curve when produced backwards cuts the vertical axis at 2 there are 2 such targets. If it cuts it at 4 there are 4 .such targets. It is clear that the greater the number of such hits necessary to sterilize a cell the greater is the shoulder of the curve and thus the greater the effect on sensitivity of reducing the individual dose.
(6) Recovery from radiation damage is complete as regards reproductive integrity within less than one cell cycle. Surviving cells, in work reported by Elkind & Sutton (1959) , had repaired their sublethal damage completely before their first postirradiation division. (The effect of this on the survival of cells following continuous treatment at about 30 r/h as with radium under clinical conditions is indicated in Table 3 . This effect is negligible in the case of dosage rates of 50 r/min.) (7) 'The system responsible for recovery in surviving cells was not attenuated by repeated exposures' (Elkind & Sutton 1959) . Dr Lajtha assures me that so far in all this type of research throughout the world only 1 clone (colony cultured from a single cell) has so far been found with any change (in this case a decrease) in radiosensitivity following radiation and that it is not known if this change was due to the radiation. Moreover, an experiment has been performed in which 94 successive transfers of 1 million tumour cells in mice have been made, separated on each occasion by the administration of 1,000 rads. The radiosensitivity, as indicated by the tumour growth in the 95th group of animals, was unchanged in spite of the fact that the total dose given to the cells implanted and their ancestors since the beginning of the experiment was 94,000 rads. (8) At doses of 300-500 rads some cells may survive the first cell division, both daughter cells of which may survive one or even two subsequent cell divisions. (9) It is known also that the presence of dead cells may change the antibody and nutrient background of the intact cells. This factor will not influence the dose-response curve but, if, as a result of giving radiation, a certain number of cells are killed and thus available as nutrient medium for those remaining, it may be that nutritional conditions will be improved, thus giving faster overall tumour growth.
Fractionation ofRadiation
If each non-sterilized cell divides before a second fraction of radiation is given, the number of nonsterilized cells is doubled. If the dose given were about 230 rads this doubling would restore the initial number of viable cells. It is convenient to remember that 7 cell divisions will increase the number of cells 100-fold and 10 cell divisions by 1,000 times. It is desirable to give a second fraction before the malignant cells divide but after the normal cells have divided. 1135 23 136 Proceedings ofthe Royal Society ofMedicine Radiation inhibits mitosis as shown by Spear (1953) in chick-fibroblast cultures, and since demonstrated for every cell type so far studied. It is important to know if radiation causes prolongation of the intermitotic interval and whether malignant cells are more affected in this respect than normal cells. In the latter event, to irradiate after the normal cells have divided, fractionation at longer intervals is necessary. It becomes important to know at what interval to apply fractions of radiation so as to irradiate the fixed normal tissue cells at intervals greater than their cell cycle, while attempting to irradiate the malignant cells at intervals less than their cell cycle. At present it seems to be impossible to estimate accurately the cell cycle in any tissue in a patient at any one time. It would be of great value to know this at the time of irradiation both for normal and malignant tissues being irradiated. There is no evidence that the cell cycle can ever change under similar conditions. This could be a legacy from the days when our protozoic ancestors were subjected to the diurnal cycle of the sun in all parts of their minute bodies.
Migration of Cells from
Outside the Treated Volume It seems likely that the normal cell population can be reinforced from outside the volume treated by cells brought in by the blood streame.g. histiocytes; capillary endothelium. Such a process could be advantageous in that it would increase the tolerance of the normal tissues by renewing the cell population. The number of hits needed to sterilize a cell is expressed statistically in the 'extrapolation number' which has already been mentioned. The extrapolation or 'hit number' for mammalian cell lines is mostly 2 but in contrast to this 5-10has been observed in surviving Chinese hamster cells cultured in vitro (Elkind & Sutton 1960) . If one hit only were needed to sterilize a cell then, provided fractions of radiation are given within the same cell cycle, the doses are directly additive, i.e. there is no recovery process due to fading of damage. It follows that if the extrapolation number can be reduced to 1 for malignant cells but not for normal cells, then, provided that fractions could be given within the cell cycle -of the malignant cell, there would be an added advantage in the sterilization of the malignant cells as compared with the effect of fractionation under ordinary circumstances. Although in cultures bromodeoxyuridine appeared to modify the survival curve to the one-hit variety, an attempt in our centre to use this clinically did not succeed. Being taken up into the nucleic acid of dividing cells the drug could only produce the hoped for effect if it could be incorporated in nearly all the malignant cells before it began to have a toxic effect on other dividing (bone marrow and bowel) cells. The drug is too costly to allow of much repetition.
The use of a low dosage rate but with a dose of the order of 1,000 rads in twenty-four hours for one week as in radium treatments, may allow initial damage in a cell to be supplemented by a second hit before it fades so that the low dose rate as in clinical radium therapy might result in a one-hit type of survival curve although it refers to cells which, with shorter durations of treatment, manifestly require a two-hit mechanism for their sterilization.
Cell Sensitization
A figure which can express the sensitivity of a cell population to radiation is the reciprocal of the log of the integer fraction surviving, divided by the dose in thousand rads, i.e. in the case of a survival proportion of 1 cell per thousand this would be log,O IO_ 3 =2J46 1-250 1 250 2
If we now compare the sensitivity of the oxygenated and anoxic populations for the same survival of 10-2 we get for the one 2 2 8=:2 38 and for the other 2-1 -0 945
The one-hit curve: As shown in Table 2 the dose to reduce the cell population to 1/2 is 145 for the oxygenated and 363 for the anoxic. For a dose of 725 rads the oxygenated population will be reduced to 1/32 while for the anoxic the same dose will cause a reduction to 1/4. The sensitivity in one case is 1 -88 and in the otherO75. If the sensitivity is doubled for both graphs the figures are respectively 72-5 and 181 5 and equal halved doses of 362-5 rads will again reduce the populations to 1/32 and 1/4 respectively. If, however, the same dose of 725 rads is givenin one case the population reduction is to 1/1024 whereas in the other it is to 1/16. 
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In other words, with 725 rads without the sensitizer, in the anoxic population 8 times as many vells remain as in the oxygenated whereas with double the sensitivity of both curves there are 64 times as many cells remaining.
Therefore with a sensitizer: (1) For smaller doses in proportion to the sensitizing factor there is no difference from the situation without it. (2) For the same doses as without the sensitizer: (a) the effect on both populations is greater and (b) the relative effect on the more sensitive population as compared with the other is greater.
It follows therefore in treating a malignant tumour: (1) That a sensitizer can help only if it affects the malignant cells to a greater extent than the normal. (2) If malignant and normal cells are equally affected by a sensitizer then the presence of poorly oxygenated cells in the malignant tumour results in greater malignant cell survival for the same normal cell survival if a sensitizer is used than if not. If complete oxygenation of the anoxic cells can be obtained all the tumour and the normal cells would have equal and maximal sensitivity which would probably be greater in the ratio of 1 -2:1 than that of the normal tissue under ordinary treatment conditions. Although theoretically possible it is difficult to know if this can be realized in practice because of unknown features of capillary blood flow.
Equalization ofSensitivity by Anoxia
The suggestion has been made by Dr E A Wright that the reduction of oxygen tension to zero will be more likely to produce a uniform sensitivity although doses of about 2j times will be required. Complete anoxia is obviously a dangerous state but if, as Dr Wright says, the cells of the C.N.S. can tolerate a time of the order of a minute without serious damage it might be possible to make use of this method. The proposal is that a patient under anisthesia has his oxygen supply cut off completely after he has been placed in position for treatment. At the instant when a potentiometer indicates zero oxygen content of the tissues an electron beam is switched on of appropriate energy to deliver a suitable single dose at the tumour (possibly of the order of 4,000 rads in a few seconds) after which the oxygen supply is instantaneously resumed. I hope to try out this type of scheme with a 35 million volt linear accelerator when we have done the necessary preliminary work on tolerance doses of anoxic and normal tissue to electron beams of various cross sections. This technique obviously requires single dose or possibly weekly treatments.
A single dose produces a maximal effect on a certain population of cells and, as previously indicated, needs to be of the order of 4,000 rads to have a 90% chance of sterilizing a tumour only 2-0 cm in diameter (i.e. 4-2 c.c volume) with half of its volume consisting of viable tumour cells all normally aerated. This, as a single dose, is too large to be tolerated but the dose to produce the same effect if half the cells were oxygenated and half anoxic would be even largerabout 8,500 rads. Fractionation reduces the effectiveness of the radiation in two ways: If each fraction is given before a mitosis can occur there is diminished effectiveness of the radiation because of the smaller sensitivity indicated in the survival curve for the first 250 rads. This is due to the fact that 2 hits are necessary on each cell.
When radiation is given, first ionization occurs throughout the cell which consists of large and specialized molecules separated in terms of Angstr6m units by large distances in water. The production of electrons and positive ions results in various active radicals such as nascent hydrogen and oxygen, HO2, H202 and HO with a short lifetime and a limited range of movement which, if they come near enough to the enzyme proteins or nucleic acids produce damage (a hit). Some of this damage appears to be fatal to the cell if reinforced by a second hit before the damage has been reversed or repaired. As already mentioned the time for this repair seems to be less than six hours and its 'half life' has been estimated at one and a half hours. The number of ions produced and the number of cells, both normal and malignant, in any tumour are all very large so that the process is statistical. If the hits were uniformly distributed throughout the cells so that each had 2 hits then all would die. The chances of a cell receiving 2 hits with increasing dose increase exponentially and so the survival curve represents the statistical chance of the cells receiving 2 hits. It follows that the larger a tumour the greater the dose needed to sterilize it.
Tumour Size after Irradiation Suppose now that a dose of about 200 rads has been given but that, instead of a second dose being given before, it is given after mitosis has occurred. 190 rads is enough to sterilize 50 % of oxygenated cells. In one cell division the number of reproducible cells will be restored therefore to the original number. If the cells sterilized have not yet disappeared, however, the number of cells in the tumour will be increased by 50%, i.e. an increase in tumour diameter by about 15 %. If they have disappeared the tumour will seem unchanged.
Repair after Irradiation of Tumours
There is a possibility that cell destruction, by setting free in the tumour the products of cell breakdown, provides a medium which stimulates the ,25 1 137
1138 Proceedings ofthe Royal Society ofMedicine rate of growth (i.e. of mitosis) as has been shown in ascites tumour cells so that, although the facts represented by the survival curve are unaltered, more rapid mitosis may produce an effect of lack of response of the tumour. If cells are destroyed and rapidly cleared away by efficient access of histiocytes while the space is filled with capillaries and fibroblasts to produce organized healing a tumour will appear to respond readily and completely. This type of effect would seem more likely with a small than a large tumour. If the dose given is such as to result in destruction of the tumour cells it is clear that all the normal cells treated will also have been sterilized and so will be unable to take part in the repair process. Fortunately, the normal repair tissues tend to spread into the space left (as histiocytes, fibroblasts and capillary endothelium) but, if the space is large, the process of filling it will be very slow and there are two other possibilities: (1) Fibrous tissue first formed at the periphery of a cavity becomes mature, contracts and interferes with the repair of the inner part.
(2) Infection occurs which tends to prevent complete repair until the margins of the infected area are fibrosing and post-radiation endarteritis has developed when the granulation process becomes halted and a radionecrotic ulcer results. For these reasons the normal tissue tolerance is the most important limiting factor except, possibly, in situations where infection is not going to occur.
For very small volumes, complete destruction of the normal cells is less important because of the ease with which tissues outside the treated volume can fill the gap. Therefore, a small tumour, requiring a smaller dose to sterilize it than a large one, may receive a larger dose with complete safety. For large volumes with relatively few cells present, as in the case of cells left in tissue spaces after an operation, the dose required to sterilize them may be small because of the small number so that even the limitation in dose imposed by the intolerance of the large volume or, even in these circumstances by the intolerance of the patient, may not be such as to render radiation treatment ineffective.
The normal tissue tolerance must, it appears, depend on one of two factors: (a) Mitosis in the volume irradiated, and (b) migration of unirradiated cells into the volume irradiated. If the mitosis of the normal cells is at the same rate or slower than that of the tumour cells then the normal tissue must suffer as much destruction as the tumour but can be renewed by the influx of unirradiated cells. If the mitosis of the normal cells is quicker than that of the tumour cells, as seems likely to be the case, then, even without migration into the treated volume, provided that fractionation can be such that mitosis of normal cells can occur between doses while mitosis of malignant cells does not, repair may prooeed while tumour destruction is going on. I understand from Dr Lajtha that while for some normal cells the mitotic interval is up to twenty-four hours, for leukemic blast cells it is over three to five days. Unless, therefore, mitosis is inhibited too much, it might be possible to choose an optimal interval. For several years I have made a practice of giving very old women with carcinoma of breast doses of 500 r to the whole area, weekly, for 7 sessions. The effect has been satisfactory and the reactions relatively small. Perhaps a weekly interval is satisfactory. Fig 3 represents the effect of fractionation on a cell population. Four types of situation are graphically represented in which the cell survival curves for fractionated radiation are given for two types of cell population. In each case the curve for a rapidly dividing cell population (solid line) is compared with that for a slowly dividing population (dotted line). It is considered that the former may correspond to normal cells and the latter to malignant cells. The division of normal cells to repair any type of injury occurs as a response to cell destruction. The first two comparisons, A, show the relative effects of fractions of irradiation on alternate days. In B daily treatments are shown with a gap in treatment after four exposures. C indicates the likely effect of doses of the same magnitude given every third day rather than daily. D indicates the possible effect when the doses are such as to result in a decreasing population of the normal cells which by a feed-back mechanism stimulates the cells to an increased rate of division as in the case of erythropoiesis. Inallthe above situations the doseresponse is the same and only the population turn- 
Radium or Isotope Treatment: Prolonged Irradiation
Radium may give such a low dosage rate as not to inhibit mitosis and the possibility of a second hit occurring before the damage due to a first hit has faded, can, theoretically, give rise to an apparent one-hit type of survival curve. If the half time for the fading of the damage due to one hit is one and a half hours the curve resulting corresponds fairly closely to a curve which has been produced by Mr T A Green and Mr W A Jennings at the Royal Northern Hospital, London (Fig 4) . If mitosis is not inhibited, then survivors from the dose given in one cell cycle being exposedin thenext cell cycle to the same dose rate are subjected again to the same hazard. Injury sustained before mitosis by any cell is not expected to persist after mitosis (Elkind & Sutton 1959 Radium implants, as we know from experience, are well tolerated. It is an advantage that, in the immediate neighbourhood of the needles, the dose is much higher than at the distance at which the dose is calculable. From the relatively low dose areas in a radium implant normal repair cells may spread into the adjacent highest dose areas. Moreover, repair cells may enter via the blood stream so that a good circulation, with minimal thrombosis occurring, may be of considerable importance in permitting this not only in the case of radium implants but also in the case of radiation from external sources. One further pointof importanceabout a radium implant is that the floor of an ulcer or the surface of an ulcerated tumour, likely to contain the least well-oxygenated cells, should be in the high-dose rather than the low-dose region.
Residual Ulcer or Tumour after

External Radiation
The practice in using external radiation of giving a higher dose to the last remnant of tumour would seem to be a good one since this is likely to be the site of the least well-oxygenated cells. Instances of this are as follows: (a) Baclesse (1951) does this in treating laryngeal carcinoma. (b) For many years I have used a radium implant to supplement external radiation where practicable. For example, for lymph node residues I have used a line source of radium in a gland, the shape of which fits the isodose curves of the line source. At the margin of the gland a further 4000 rads may be given after a full dose of external radiation; normal tissue tolerance is not exceeded and the middle of the gland, where the cells are least well oxygenated, gets a dose of tens of thousands of rads.
(c) After external radiation of an ulcerated breast carcinoma, the condition often improves to leave .. , , _ %7 1139 1140 Proceedings ofthe Royal Society ofMedicine only a small ulcer or tumour. A very local excision of this would theoretically seem to be good practice and practically it is successful in cases where more extensive surgery is not desirable. (d) Radioactive colloidal gold may be used to replace the fluid in a necrotic liquefying metastatic node as a means of giving the necessary high dose (in this case with beta radiation) to anoxic cells as a supplement to external radiation. On a number of occasions such glands have been made to clear up even when they have been on the verge of ulcerating.
Radium Combined with External Radiation
It has been my practice for many years to combine radium treatment with external radiation, the idea underlying this combination being to get what I felt from clinical experience were the advantages of radium work with the freedom of external radiation from inaccuracy and inhomogeneity of dose. The result of this combination is to reduce the very high doses and to raise the low doses due to radium only. The very high local doses, within the volume at the surface of which a dose is calculable, seem likely from cell-survival curve considerations to be of great importance in bringing about sterilization of a tumour.
Surgery Combined with Radiation
On the cell-survival facts outlined above certain principles of combining surgery with radiation seem to be justified. After radiation to tolerable doses it seems likely that in a large tumour a large number of malignant cells may remain capable of unlimited reproduction. The outlying tissues are less thickly populated by tumour cells than is the clinical tumour and they are more likely to be well oxygenated and therefore more sensitive. Thus it would seem justifiable to combine radiation with excision to remove those cells still capable of division even though cutting through tissue capable of healing but with possibly no tumour cells capable of indefinite reproduction. The question arises of whether radiation should be pre-operative or post-operative or both.
If a single dose of 400 rads is used just before operation the number of oxygenated cells in the surrounding tissues through which an incision is to be mu de and which may contain a few malignant cells among the millions of normal cells will be reduced to 15 %. In the tumour itself the anoxic cells will be reduced only to 85 %. A given number of cells set free into the circulation during the handling of the operation will have a reduced chance in these proportions of growing as metastases, but careful handling to minimize the number of cells set free is clearly important.
A course of post-operative radiation would destroy more of both the normal and malignant cells and improve chances of survival. It is important to start post-operative treatment as soon as possible because, with passage of time, more cell divisions occur and thus the chances of complete destruction of a tumour are reduced, and also collagen replaces fibroblasts and capillaries so that malignant cells may become surrounded by avascular tissue, poorly oxygenated and thus relatively insensitive. It is important, however, that wound healing is complete before radiation treatment is well advanced since, otherwise, the repair cells are sterilized and healing may be prevented.
Post-operative radiation, after the removal of the main mass, seems to have a better chance of success than radiation only. Suppose a tumour of about 5 cm diameter containing a maximum of the order of 101l cells could be given a dose of radiation reducing the cell number to 103 viable cells. This would still be a large number from which in 20 cell divisions a tumour of the original size could be produced. The same dose of radiation, equally tolerable by the normal tissues, could, assuming about a total equivalent diameter of 5 mm of malignant tissue, result in local cure if given to the tissues surrounding the operation area.
This reasoning can apply to any tumour, whether primary or metastatic, and it follows that the higher the number of anoxic cells present the greater the need for removal if a local cure is to be arrived at. On the other hand, if too much malignant tissue has to be left behind, there may be no great gain in surgery and there may even be a loss since there is the possibility that the surgery may increase the rate of mitosis of the malignant cells either by local or systemic influence in a similar way to that by which normal repair processes are stimulated to heal by the incision.
A pre-operative course of treatment would not be likely to sterilize completely a large tumour mass or extensive palpable infiltration and therefore we must consider that the operation, to be carried out if possible before mitotic division of the malignant cells has recommenced, should be performed by cutting outside any tissue known previously to be infiltrated by neoplasm. Any such tissue is likely still to contain viable malignant cells which may be disseminated and possibly stimulated to activity by an incision.
If a large dose of radiation can be applied locally at the time of an operation to a region suspected still to contain cancer it would seem to be a good thing to do. In relatively acccessible situations this can be done with radium or tantalum wire implants and combined with the usual type of external radiation. I hope to be able to achieve the same purpose by applying a large dose (say 28 Section ofRadiology 2,000 rads) very quickly with an electron beam to a suspect site at the time of operation on otherwise inaccessible cancer. The energy of the beam can be adjusted to the depth of tissue to be treated to reduce the likelihood of radiation sickness.
From the point of view of surgical repair of tissue previously irradiated to a cancer treatment level we must consider that the cells of the normal tissues lie dormant but must divide when damage has to be repaired. If a high proportion ofthe cells have lost their reproductive integrity the repair processes may be deficient. The deficiency will be aggravated if the damage occurs after six to seven months when the vascular and connective tissue changes due to the radiation have, by fibrosis and endarteritis, so reduced the blood supply and the tissue spaces that non-irradiated normal tissue cells cannot enter the area in as large numbers as normally. Such a situation might, of course, arise as a result of trauma due to infection or injury as well as a surgical procedure. It follows that early surgery after radiation has a better chance of successful healing than later and that after six months the conditions are worst. It also follows that a surgical repair of irradiated tissue by a split skin graft is best carried out as soon as possible. For instance, if tumour has been removed from antrum or middle ear and radium applied to the cavity, the application of skin to the cavity, other things being equal, would be best carried out one to two days after the radium treatment when the blood supply is least impaired and the unirradiated cells of the graft can take on the prepared surface. To apply a graft before the radium treatment will give it a very poor chance of taking. For cover by fullthickness skin graft with an intact blood supply the union should have normal skin at least for one flap. Healing may then occur by first intention, whereas if both flaps have been heavily irradiated they are less likely to heal. Most of the scar tissue under these circumstances is provided by the cells from the unirradiated skin.
Can Tumours be Cured by Radiation.? From the considerations discussed in this paper so far the burning question seems to be 'Can radiation cure cancer?' It is continually reiterated that the only proof of cure is the proved absence of cancer on the post-mortem table. Thus cure can never be proved. What of the patients we know who have lived for many years after radiation? Can we be sure that they will not develop clinical evidence of malignancy at the site treated? The approximate number of cell divisions needed for a tumour to grow from 1 cm diameter to 5 cm diameter is 7, but the number of cell divisions needed to reach 1 cm diameter is 27. In a patient developing a recurrence therefore, even twenty years after treatment, sixteen years of steady growth might have occurred before any tumour could have been appreciated, after which apparent rapid local progress associated with increasing likelihood of metastases may proceed apace. This kind of situation is not uncommon. Nevertheless most radiotherapists would consider that certain tumours may have been cured by radiation. I, for instance, have a patient nowabout 34 whom I treated twenty-eight years ago for lymphosarcoma of the rectum. Many patients remain well twenty years after treatment but the possibility of complete cure is always open to question. Of course, the same stringent criteria must apply also to surgery. For accurate conclusions the need for continued follow-up and accurate histology even of rodent ulcers seems necessary. However, for what may be considered reasonable treatment and follow up, less rigid criteria need be applied and the judgment of the clinician, whether radiotherapist or surgeon, is important. If, as I have seen in a patient after a radical mastectomy, the development of a 5 cm recurrence has taken twenty-five years and if one considers that this requires at least 34 divisions approximately one can deduce about one cell division per annum. It may be possible that all the cells do not survive. If it is assumed that 75 % die for various reasons a rate of 3 per annum may be deduced. If a similar 5 cm diameter tumour can grow in a period of six months then on the same assumptions the likely intermitotic interval would be about two days to one week. Perhaps, by using this type of information, we might be able to decide on an optimum frequency of fractionation since it is logical to aim at a spacing of a maximal number of divisions of the normal cells between fractions, before division occurs of the malignant cells. It is necessary, however, to know more about the frequency of cell division and about the proportion of cells dying both before and after radiation in a malignant tumour.
The tumour bed may be very much concerned with the effects of radiation. We must, however, realize that although cells may not be able to grow as well on one medium as on another, the facts about the relative constancy of the dose needed to sterilize a given proportion of cells remain the same. But just as one medium outside the body may promote growth and even result in the death of cells better than another so in the body it may be that the stroma and the diffusible substances present in tissue fluids may have similar influences. In the body, moreover, immune reactions may be influenced by radiation and these may have profound effects on the survival of malignant cells. The association of the presence of lymphocytes in a lympho-epithelioma with high radiosensitivity lends point to this suggestion in 1 141 29 1142 Proceedings ofthe Royal Society ofMedicine 30 view of the gammaglobulin content ofthe lymphocytes. Moreover, similar considerations might be important in connexion with the very high sensitivity of some reticulosarcomata which appear to be completely cured by doses of 2,000 rads in 4 or 5 fractions.
Some experiments by Murphy which I read about thirty years ago have greatly influenced my thinking. He investigated the effect of radiation on the viability of breast carcinoma cells implanted under the skin of the back in mice. The criterion was the percentage of takes. He showed that a greater effect was produced if the tumour bed and the tumour were irradiated than if either alone was irradiated but that the effect of irradiating the tumour bed before implanting the malignant cells was greater than that of irradiating the tumour cells. Clinically it is a parallel procedure to irradiate pre-operatively the carcinoma and the operation field into which cells might be implanted just before surgery, to the kind of dose used in those experiments.
Radiosensitivity
From the dual consideration of tumour cells and tumour bed we can consider apparent radiosensitivity of a tumour as indicated by its clinical behaviour. If, when irradiated, a tumour shrinks rapidly it is radiosensitive. If it grows bigger or does not shrink at all it is not radiosensitive. While, if it shrinks only slowly or after a long time, it is moderately radiosensitive. The conditions favourable to radiosensitivity are summarized in Table 4 . Chemotherapy and Radiation Chemotherapy is a method of damaging cells by chemical substances which can be used systemically or, by slow or rapid intra-arterial administration with suitable precautions and large doses, regionally. If the effect is on mitotic cells only and those not in mitosis are undamaged, then chemotherapy is different from radiotherapy. If, however, it acts on all the cells so that subsequent cell division is affected as in radiotherapy then its effect is similar. If, however, it is different we might expect a greater effect by combining radiotherapy with chemotherapy than can be achieved otherwise.
In conclusion, considerations of these new cellsurvival experiments must influence our thinking about tumours and radiotherapy, providing explanations of our past observations and constructive hypotheses for future work. They underline the need for accurate knowledge of dose given, the need for as high a dose as is compatible with normal tissue tolerance and the desirability of making the dose higher still where there is no normal tissue present as in the middle of a necrotic gland or where severe damage to normal tissue can be tolerated. The necessity for rational, close and continual co-operation between the surgeon and the radiotherapist becoomes more obvious both in treating malignant disease and repairing radiation damage. In addition, these suggest that treatment by fractionated methods may require revision. Possibly the most important necessary determination for rational fractionation is of the duration of the cell cycle, especially during a course of irradiation, both for normal cells and malignant cells in individual cases. Dosage inaccuracies in radiotherapy due to poor planning and lack of correction for tissue heterogeneity can be seen to be more important than we have hitherto considered them in relation to the number of cells spared by a 10% or 20% diminution in dose. Similarly, treating all the fields for a given volume at every treatment seems to be of greater importance than has hitherto seemed likely.
Finally our basic thinking regarding the management of cancer patients must be modified to fit these new facts. This applies especially to the possibility or otherwise of cure, to the use of tenyear or fifteen-year follow up for assessing the relative merits of two methods, and to the importance of modifying the rate of growth by modifying the soil in which cancer grows.
